Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.
Cholesterol Treatment Trialists’ (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk None. and Cholesterol Treatment Trialists’ (CTT) Collaboration None., (2024), Lancet Diabetes Endocrinol, 12, 306 - 319
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.
Cholesterol Treatment Trialists' Collaboration None., (2022), Lancet, 400, 832 - 845
Individual participant data meta-analysis of muscle symptoms in large-scale randomised double-blind trials of statin therapy
BAIGENT C. et al, (2022), The Lancet
Harmonisation of large-scale, heterogeneous individual participant adverse event data from randomised trials of statin therapy.
Cholesterol Treatment Trialists' Collaboration None., (2022), Clin Trials
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials.
Cholesterol Treatment Trialists' Collaboration None., (2019), Lancet, 393, 407 - 415
Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) - results of a randomized controlled clinical trial.
3C Study Collaborative Group None., (2018), Am J Transplant, 18, 1424 - 1434
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials.
Hacke W. et al, (2018), Int J Stroke, 13, 175 - 189
Interpretation of the evidence for the efficacy and safety of statin therapy.
Collins R. et al, (2016), Lancet, 388, 2532 - 2561
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.
Cholesterol Treatment Trialists' (CTT) Collaboration None. et al, (2016), Lancet Diabetes Endocrinol, 4, 829 - 839
Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 Trials.
Lees KR. et al, (2016), Stroke, 47, 2373 - 2379
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis.
Whiteley WN. et al, (2016), Lancet Neurol, 15, 925 - 933
Protocol for analyses of adverse event data from randomized controlled trials of statin therapy.
Cholesterol Treatment Trialists' (CTT) Collaboration None., (2016), Am Heart J, 176, 63 - 69
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.
Cholesterol Treatment Trialists' (CTT) Collaboration None. et al, (2015), Lancet, 385, 1397 - 1405
Alteplase for acute ischemic stroke: outcomes by clinically important subgroups in the Third International Stroke Trial.
Lindley RI. et al, (2015), Stroke, 46, 746 - 756
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
3C Study Collaborative Group None. et al, (2014), Lancet, 384, 1684 - 1690
Efficacy of aspirin in people with diabetes: an individual participant data meta-analysis of 26 randomised trials
Wong CX. et al, (2014), EUROPEAN HEART JOURNAL, 35, 1020 - 1020
The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal Protection.
Herrington W. et al, (2014), Clin J Am Soc Nephrol, 9, 914 - 919